What is the Knee Pain Market Size?
According to 6Wresearch internal database and industry insights, the knee pain market was valued at USD 9.8 billion in 2024 and is projected to exceed USD 16.5 billion by 2031, growing at a CAGR of 7.5% during the forecast period.
This market is expanding due to the increasing the rise in the number of older people, the rise in the number of people with osteoarthritis and sports injuries around the world, and the growing interest in new and non-invasive ways to treat pain. Biologics, regenerative medicine, and advanced intra-articular injection solutions are all becoming more popular, which is helping the market develop. Patients are also choosing long-term relief choices and better mobility outcomes more often.
Major Growth Factors of the Knee Pain Market
- Rising incidence of osteoarthritis and joint degeneration
- Increasing number of sports injuries
- Growing aging population
- Rising demand for regenerative medicine
- Expanding access to healthcare in developing regions
- Strong investment in R&D and orthopedic innovation
Knee Pain Market Trends
The knee pain market is witnessing strong growth in biological and minimally invasive treatments, with an emphasis on regenerative methods including PRP (platelet-rich plasma) and stem cell injections. More and more people are using individualized programs for managing pain, wearable gadgets to relieve pain, and digital solutions to keep an eye on chronic pain. The market is also being shaped by new ideas debuting in drug delivery systems and near-orthopedic implants.
Emerging Developments in the Knee Pain Market
The knee pain market is rising with the development in injectable biologics and targeted treatments is growing quickly. Companies are working together in smart ways to produce precise medicine and better diagnostics. The market is also changing since the FDA has approved new therapies for knee pain and telemedicine platforms are growing to help people manage their pain from a distance.
Major Companies in the Knee Pain Market
- Johnson & Johnson
- Zimmer Biomet
- Smith & Nephew
- Stryker Corporation
- Bioventus Inc.
- Sanofi
How big is the Knee Pain Market : FAQ's
The knee pain market was expected to be valued at approximately USD 9.8 billion in 2025 and is projected to reach around USD 16.5 billion by 2031.
The knee pain market is anticipated to grow at a CAGR of 7.5% during the forecast period.
Key trends include a rise in non-invasive and regenerative therapies, the integration of digital pain management tools, and growth in biologic-based treatments.
The knee pain market is driven by increasing joint disorders, aging demographics, sports-related injuries, and innovations in treatment methods including medical devices.
6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on
sales@6wresearch.com